Physician profile
Kunj Desai
NPI 1174767495
$6,069.27
in general payments reported to CMS, 2019-2025
21 companies · $945 in 2025
The $945 reported for 2025 was more than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,285 · 2020: $93.83 · 2021: $1,438 · 2022: $669 · 2023: $1,247 · 2024: $392 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,831 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,831.04 |
| Travel and Lodging | $752.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,658.85 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Medinc of Texas | $1,207.44 | 2021 | |
| Mission Medical Distribution, LLC | $970.54 | 2023-2025 | |
| Checkpoint Surgical, INC | $379.56 | 2019-2025 | Checkpoint Stimulators |
| Acumed LLC | $356.08 | 2022-2024 | Innate Implant, Inframe Implant, Acumed |
| Ensemble Orthopedics, INC | $301.60 | 2022 | |
| Skeletal Dynamics INC | $255.81 | 2022-2025 | Geminus, Align, Implate |
| Arthrex, INC. | $186.40 | 2023 | |
| Trice Medical, INC. | $172.20 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $150.47 | 2020-2023 | Xiaflex |
| Access Pro Medical, LLC | $96.31 | 2023-2025 | Matriderm, Matriderm |
| Vertex Pharmaceuticals Incorporated | $59.06 | 2025 | |
| Depuy Synthes Sales INC. | $43.01 | 2022 | |
| Ossur Americas, INC. | $42.28 | 2024 | I-Digits Quantum |
| Avita Medical Americas, LLC | $37.27 | 2023 | Recell |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $32.41 | 2019 | |
| Endo USA, INC. | $29.30 | 2025 | Xiaflex |
| Dilon Technologies, INC. | $26.04 | 2025 | Hemoblast Bellows |
| Anika Therapeutics, INC. | $23.40 | 2024 | |
| Alafair Biosciences, INC. | $21.33 | 2022 | |
| Polynovo North America LLC | $19.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunj Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.